Oncotelic Therapeutics, Inc. Restructuring and Related Cost, Cost Incurred to Date
Oncotelic Therapeutics, Inc. (OTLC) had Restructuring and Related Cost, Cost Incurred to Date of $1.23 million as of 2011-12-31, per its 10-K filed 2015-03-30.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2015-03-30
- 2011-12-31: Restructuring and Related Cost, Cost Incurred to Date $1.23M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2011-12-31 | $1.23M 10-K · filed 2015-03-30 |